N
Google TrendJONAS BROTHERS (500+) — Jonas Brothers postpone Birmingham concert over weather concerns
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:jonas brothers500+steven kwan500+kings vs warriors200+steffi graf200+boxing200+ben simmons500+lisa500+bill maher500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "CAR T Cells Produce 10-Ye" (30 stories)

Top Headline Story

CAR T cell therapy leads to 10-year remissions in B-cell lymphoma patients
Lead StoryPenn Medicinegeneral
Jun 24

CAR T cell therapy leads to 10-year remissions in B-cell lymphoma patients

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOQkE2NXA4S0pob3FaQVc1Uk1kSDBJSlgwRVBnUzQwTWRNeGxLOXoydnNkaFhUTzdzbklGNTdpaGYtOEVRU2czWjh1c0doQjVxd3NMQ2h1bElUYl9Kallsc3c0WHo4dXZxYkNvanZGSkphLVo3OEFPUW1HdmZKUE9aUFlqR0N3MXVmeWxGMzQ2bHZSX2k2?oc=5" target="_blank">CAR T cell therapy leads to 10-year remissions in B-cell lymphoma patients</a>  <font color="#6f6f6f">Penn Medicine</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+15m ago

jonas brothers

Jonas Brothers postpone Birmingham concert over weather concerns

Filter stories
500+15m ago

steven kwan

Guardians' Steven Kwan Could Shake Up Winter Outfield Market

Filter stories
200+15m ago

kings vs warriors

3 Storylines I'm Focused On in Warriors Preseason Game vs. Kings

Filter stories
200+15m ago

steffi graf

PICTURES: Steffi Graf & Daughter Jaz Feature In Andre Agassi’s ‘Photo Dump’ As Carlos Alcaraz & Karl-Anthony Towns Make Surprise Appearance

Filter stories

Search Results for "CAR T Cells Produce 10-Ye"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
CAR T Cells Produce 10-Year Remissions in Some Patients With Lymphoma
Medscapegeneral

CAR T Cells Produce 10-Year Remissions in Some Patients With Lymphoma

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPc2Vvc3hENmszTjd5dmMxVHZfVUk1SWZEWmxDanhuMmw2RWRTZ3ZTUWREVERRa2Q2cC1BWEpaNXlheVZlSi1YcXdHbUZ2bW9zaWxBWWVXYWdvWkRXbm9BU3dGSE9tX0FYcnEydm5PcnVwXzdXOVM2YmNHVUxvQWlJWElrYngzaHlSQ05oVXRuVmFoemlHTW5TYUthcHZRN3pfaG1vTQ?oc=5" target="_blank">CAR T Cells Produce 10-Year Remissions in Some Patients With Lymphoma</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Ten-Year Follow-up Shows Durable Remissions After CAR T-Cell Therapy for B-Cell Lymphoma
The ASCO Postgeneral

Ten-Year Follow-up Shows Durable Remissions After CAR T-Cell Therapy for B-Cell Lymphoma

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNYXdUS3dEVWJkU2JjNmlQbVotYTUySkJCbVpXbzBwQkZCWFJZdDJrLXRqUHo4TDhNS0s5ZzBxeTJWRDJGNjY2dEw3RHNXRm52ZllQYUFMZ0JtTXF1S0k2V2xyZldrckhKY05YUHhLeWs5MmtTOGRZTExUd1R3XzNOUDJKUkhnOC1DdUgyeUhMRzhudzdDeUVTcUQ1N2hVdzROYUxvWEhtSjhXOWc1ZjRmMDY0UXJxNWRJbnFhbWx0ZHl2Qmc?oc=5" target="_blank">Ten-Year Follow-up Shows Durable Remissions After CAR T-Cell Therapy for B-Cell Lymphoma</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Long-Term CAR-T Results in Lymphoma Confirm Early Promise
MedPage Todaygeneral

Long-Term CAR-T Results in Lymphoma Confirm Early Promise

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTFBvV292SnJGTHN2czRGZTFlYi1Ta1F2OFRzSmVySVo1US1peU9aMmVaTnBjMi1GSzZRVWh4dGNoR3Yyel9lR3JnUUx4YTFjcXNOQ3VlYWRfZXRJbFk4TTg1RGdSczFEdGx5cDJJdkpjQm0?oc=5" target="_blank">Long-Term CAR-T Results in Lymphoma Confirm Early Promise</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
Celebrating 10 Years of CAR T-Cell Therapy at UNC Health
UNC Health Talkscience

Celebrating 10 Years of CAR T-Cell Therapy at UNC Health

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPTjhMNGZmdk13ZGpMYVRNUG84SWdELVpfbnkydGw0UXJMOFlrYl9UdnhtSzlUVGIyM25iemVjd3hjeUhNLUpidmtHaEFVNW9aRHFxdEMwTXZ3cTdrY2pNM1lQTHJRQ0EzM0hnTElYLVFxbF8ySlZfVVRmMWtoNy0wdHROYWZkdjFPR0RpTVZxWG9uWUVZd1JmWUV30gGfAUFVX3lxTFBfYzIyR3NGZmFBc3BSdldmanQtY1VqVGVUeThLOTBaSUJzY18ySHRVM1F2czZKWHFYOENMTXYzUE02bF9SQVV3c1dESE05UkJGUm9DRXFJWlkzdE9FdXBlaUh2cENfaXczdl9SalkzSEd2Vi15dS16UkhTR2pWdDJoMF9yMHZqaEtGd244azlKSkVzYTdQTWZOUy1CZF9QTQ?oc=5" target="_blank">Celebrating 10 Years of CAR T-Cell Therapy at UNC Health</a>  <font color="#6f6f6f">UNC Health Talk</font>

Read Full StoryMore like this
This Week’s CGT News: Antifreeze Sugars Protect CAR T Cells
The Medicine Makergeneral

This Week’s CGT News: Antifreeze Sugars Protect CAR T Cells

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPeWl1UW5pcDlRSGF0bFZMZFpJeHR3OWdyNHF3R0pMa0ZBamZlZlg1dU55b055a3BlT09HaldfLThFNTlENlNrZnFVLTBLWDg2dWpVV3phSWxWUVlJeGxzd01fa2JMOVAxOFlzQU5xT0lxSEtmaHFZb1RkTi1PbmhrdXNJMkdjYW90YjZJYV95cElLLXJtN2dxOTJNVjZ4U3IxMUJYRmNHb2w1bHZVa0RkanZ2LTh2N1E?oc=5" target="_blank">This Week’s CGT News: Antifreeze Sugars Protect CAR T Cells</a>  <font color="#6f6f6f">The Medicine Maker</font>

Read Full StoryMore like this
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel
Business Wiregeneral

Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxQaW1EVGNPTElpcGFoWFdwam0tYU9GLWVhTnBJbmRqZUowT0QtLVdSRkl6N3JycW9qZm5EaThKc1hwdWl2ZWx5TUdBek5PSDF4QlpsZkxBUGgxRTY4M1dtQzlYUnJKcFJRYzZQa2hPcmMyV3hGcjA2emVBVUR4RElEMHZKSV9ON213Y1lZMzJVMUNqMDNQMHBIX0JLWUxYZ2t1dlpnSWdodlpxQXFwdDdla0R3eXIxNW9JSzIzMHdaQU8yZ0loNE40WGVobzA2LUNqZnhJSnJjUldiZw?oc=5" target="_blank">Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Decade-long persistence of CD19 CAR T cells in B cell lymphomas
Naturegeneral

Decade-long persistence of CD19 CAR T cells in B cell lymphomas

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5OU194N01jMmpfNE9xM3dWc3l4Y252OHJlUjh2V3FUc1dvYnk1N2R5UXJmNGZ5NXdnSmZxenl0azJjUFNSZ210cVpoWUZUOWg2LWlHbnlqbmpKYUFhREVR?oc=5" target="_blank">Decade-long persistence of CD19 CAR T cells in B cell lymphomas</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells
PBSworld

Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNLXBISE5GSFVSU0J3LXdlTUpVcmZsb1gtcU1MRFlCSW81UUVRNUMtaWVqVV9ESTJuYXJGYXg4SjZDY0Fsa01waU53bUZkYUJsZUJ5eVFZc3I3bVRQejBJQXIxaVRZWFMyVmx2ZHRyZy1HQnJqa1dVeW1HSzFkV3NzN2ZkeXkyWGZ6WnJtUElyWnRQUm1tS1Zpb1Ryc3dnRnN1NGJNRmdINU1WTnJpcjRQUkk0U1FWMFRYcmR2bkhIMnVnUQ?oc=5" target="_blank">Scientists explore new frontier in autoimmune disease treatment by resetting 'rogue' cells</a>  <font color="#6f6f6f">PBS</font>

Read Full StoryMore like this
CAR T cell therapy leads to 10-year remission for B-cell lymphoma patients
Oncology Centralgeneral

CAR T cell therapy leads to 10-year remission for B-cell lymphoma patients

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNWkhGZllyNDhaNkUzNGZyUWU3NndWdzZJUkdGUWpjMk93ZTMtZ29RN0FiN1lNZU9pX3p4V0Y5VmZzeXF4TWJjaC1YVVBTYVBDcldodjAxMmluTmpfNmNWQ1NOYk1jTVR5ZlZTS2IyTEs0dFJlNlFaOGF4a3NtTGl0ak4tZlJBU0RXWWFLR3pjTFdhQ09ySm1QWXRsX0h4WlhUeUE?oc=5" target="_blank">CAR T cell therapy leads to 10-year remission for B-cell lymphoma patients</a>  <font color="#6f6f6f">Oncology Central</font>

Read Full StoryMore like this
Unlocking the promise of CAR-T
Harvard Gazetteworld

Unlocking the promise of CAR-T

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxPdHpsWE5leXV1UWpVTGdYbUZZalFjdU1TN0JsYjU3TXgzUzhoS05SX2JONjEtRjZVRWtrb3c2YjV2eUFBWkc5N2RrSEpTajY0bjJjZVN6VFluTTBtUUVXcXY1Z3pWRjZpUVR1Q2hMUFh5TkZscE8xRlF0U2ZwV1JkYjlldjE?oc=5" target="_blank">Unlocking the promise of CAR-T</a>  <font color="#6f6f6f">Harvard Gazette</font>

Read Full StoryMore like this
New insights on potency assays from recent advances and discoveries in CAR T-cell therapy
Frontiersgeneral

New insights on potency assays from recent advances and discoveries in CAR T-cell therapy

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNZ1poNUhoeFQ0ZWVIbHN5NGdFZE5QVW1ZLXRFVlhDOVM5UGJwekpvY09IUUhJRGstOEMtd05PSjY4dXFpckk4blgxZTM5RkVxTE1uaUkzemdxNXpjQVFmaENnT3BpU0N2b0gtNEVCTXBzdFQ3OEx3c2taM1p2UTFCUU9QeGgtWkVYbmNYZkpVNGZadw?oc=5" target="_blank">New insights on potency assays from recent advances and discoveries in CAR T-cell therapy</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Emily Whitehead, First Pediatric Patient to Receive CAR T-Cell Therapy, Celebrates Cure 10 Years Later
Children's Hospital of Philadelphiageneral

Emily Whitehead, First Pediatric Patient to Receive CAR T-Cell Therapy, Celebrates Cure 10 Years Later

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOLTZZTDV0S2R6OHA2eDEtYlVFU1loNm1GX2g4WlhBQkZPTTFWV09hdDZDaU5FWi10MmN4OWRqcGtFaWdqVVUtYUdMSjFsdGEwbkk0UW5mb25GUWsyMkJfbFhqcnR3MnBtbXNhamo4UmNSaVFUVXlkMTYtZ3BzTXhNd2Zpc29CYWw5Ul9EeFhnSmtoZzJhLUY2WUdqaEljSFBuNHRtWXlmZU5fSEhqT1EwRVc0dVJPLVFa?oc=5" target="_blank">Emily Whitehead, First Pediatric Patient to Receive CAR T-Cell Therapy, Celebrates Cure 10 Years Later</a>  <font color="#6f6f6f">Children's Hospital of Philadelphia</font>

Read Full StoryMore like this
CAR-T cell manufacturing: Major process parameters and next-generation strategies
Rockefeller University Pressgeneral

CAR-T cell manufacturing: Major process parameters and next-generation strategies

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQWEVneER1b2VZdG9HaVVYMExHdWQ1ejFZUDBaTzlvQTlVZ014c0NQVnozV3VfeTdzTHdkN3RvMG12TWJaZi1oaEdMSDFuX2kzWUJCNGNlNWdyU2ZYVmtpc3ItSmNhVkdZTU41UlMzRmMxWnVlc3hvNHVBXzU3Z2RDQUxwU0Fod0toaFFSVi1ncWs1QnVkMFRleklNa2xuVHlGQ0RoWUNlRQ?oc=5" target="_blank">CAR-T cell manufacturing: Major process parameters and next-generation strategies</a>  <font color="#6f6f6f">Rockefeller University Press</font>

Read Full StoryMore like this
Chimeric autoantibody receptor T cells clonally eliminate B cells producing autoantibodies against IFN-γ
Science | AAAStech

Chimeric autoantibody receptor T cells clonally eliminate B cells producing autoantibodies against IFN-γ

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE9QVldpUHRXd3dJcktoY0NtLVZfWXlkMVhZXzA4SE1IRVBaVW13bmZOUU9FXzRYVFpwN1B6RklZMU1qUXlnRUlCM1lWQ0dUbm9MV2VqUUVVQndKUXpqVFQ2dHBISzg?oc=5" target="_blank">Chimeric autoantibody receptor T cells clonally eliminate B cells producing autoantibodies against IFN-γ</a>  <font color="#6f6f6f">Science | AAAS</font>

Read Full StoryMore like this
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
Natureworld

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE02Vzl5MzFWbUpoWUFpMHNJZG90bGxIV0JUNnlMbTZqenNJaGZPdk5QdWk3dlpzWXE3MEZ3X0M4eDI4b25EQzYyZEt0U0xJYjNGa2ppNVByQXNndHdKSk9z?oc=5" target="_blank">CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study
Naturegeneral

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBfdEFJTHpmVFJyQ3Q3YXlVcFh5THQyMXpRTWY2S3l2YTBaalBDakl3b3l5NTZhOGxleGZ0c0V1NEF4Yk9acHBPMk16QW9SOURhWXRvRTlLcTBQZUtKazI0?oc=5" target="_blank">Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
Natureworld

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5DakVxaG5zZFI0Zk9BLWdFRnRsS3JuMHp2RHlqVmN5Mno2ZVRqMlBPQ3pSeUxjY0dpb0ZmOXBWT1VBZUxLalhGckx2WDQ2LVJQanlnRTVvejB5ZHV1Nno4?oc=5" target="_blank">CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapies
Naturegeneral

Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapies

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9BenczY0xjWGg2VDhWOVZ1YWZnZGtUQTZfTjktQnQ2NTlJQ1RJWFFTb3Q4YmRJM1gyY1dsTUdhMkE0XzNfVE1XbWYyREVoMlFzSDRaY3k0dmJkc1ZxSU1v?oc=5" target="_blank">Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapies</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon
Frontiersworld

CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOdVNpemYxMWNhUXkwaV9reHp2dmNpeVVHTkdRckFyTjhnRFd3RXJqYzV5TEk0V3hHUm9zTk44SFFNUVBxZmJUbENKSnZ1dlpMWDBlUWZMSkcyMnFRY0hRX25jc0p1V2U2Z1V4YWp5d0tyX3hkTE5tc2NsTVd5S1ZGWWk2cVFLMUVOUXZhZkJ0VjdNQQ?oc=5" target="_blank">CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Study reveals new details about decade-long persistence of personalized ‘living drug’ cells
Penn Medicinetech

Study reveals new details about decade-long persistence of personalized ‘living drug’ cells

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOTFZHaHRpbHZrYUtXZG5mNlJvdWZ0ZnAxTEN1clNDckcwTkxCSDZSWldpTjJqdktCVGJxTTNLM1M1cUZnbndjUEx3TnJMSVZ2V2I3UUF0MW00Y1VKdHpoQjZTQWZsLUZ0TnFETmIxN0lVaEIwZWZUbVZlQTBqZnk4LW1KUTRCTDc0dTI0QUZueFJpWXE0N1N3dnIwOEs2R0RKSmtCeGstY3hneFN2dFhIOTRjSWVuVFltREE?oc=5" target="_blank">Study reveals new details about decade-long persistence of personalized ‘living drug’ cells</a>  <font color="#6f6f6f">Penn Medicine</font>

Read Full StoryMore like this
To speed patient access, Allogene scales up CAR T cell products
Drug Discovery Newsgeneral

To speed patient access, Allogene scales up CAR T cell products

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQNG5iMWlqMnVrM0ZSNnNldVVyd01IN0NlY05PM0ZNQk53VXB4RGF2YUFvSGRPRWt2T2RfblV3TjIzaEFKNEE5Nko2LVNYdzJqTVRJUW5VLU5JcjJjUDFndnlSMGxLbWpRbDhWYjZYdERuZi11SWtBbDhLbmswNDdtOFB6OEtxZTgyend2MG1tZXVoUXFXUmhTYjJEMFdyT0lnRkhSRw?oc=5" target="_blank">To speed patient access, Allogene scales up CAR T cell products</a>  <font color="#6f6f6f">Drug Discovery News</font>

Read Full StoryMore like this
Woman in cancer remission for record 19 years after CAR-T immune treatment
Natureworld

Woman in cancer remission for record 19 years after CAR-T immune treatment

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5JU0NMZElCQnk2ZUxabVJGWkNCeWJJNUhUOE5iWkRpa0NQVWd1UkhsUnU1d0RZaGlVb243OGh6YnloOWZaWVhxVE5YM2tnYjdEX3RWelRCT3czdEpha2Rj?oc=5" target="_blank">Woman in cancer remission for record 19 years after CAR-T immune treatment</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Science Firsthand: Translating the promise of cell therapy
Bristol Myers Squibbscience

Science Firsthand: Translating the promise of cell therapy

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNV2gzUHZSZDY3ZmtGSmo2NUtiLTFWS2hTeXV2RUdNWEtTODBMU0lBY0tVby1OVFBoMWF3LWV5MVdvaEhzU184YlNNT2FVMEhEMGlMY05MYzlrbW1uX29VS3Q0WjA2ZjgyTzZXNVpKbXNGUHVteHBaM1hhVGN2YmltcnRJY2Zsems?oc=5" target="_blank">Science Firsthand: Translating the promise of cell therapy</a>  <font color="#6f6f6f">Bristol Myers Squibb</font>

Read Full StoryMore like this
The Remarkable Success Of CAR T For Lymphoma 10 Years Later
Forbesgeneral

The Remarkable Success Of CAR T For Lymphoma 10 Years Later

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOVmE5b1BsTFRyWWhfNVo4S1BJbV8xbjU3UW1zeFFkWU9hd2Ywc2pVRXpINDF6ckRqOGRUWEI5ODRsX2dMT1BLX3F2VWdlMmx4RGh4bGtYclRlOGtLaWh3TUt4bkFJSXBZdGRzRTM3UnRPUm1SSC1uN3NZR0Npc3VTeDJhVEs0blVvcmp2Q2tiZjhVZTZhNXpVVVIxeFczTkM5aWI0ZldLTzJmMmZGZ1FoUzNGMjM2dw?oc=5" target="_blank">The Remarkable Success Of CAR T For Lymphoma 10 Years Later</a>  <font color="#6f6f6f">Forbes</font>

Read Full StoryMore like this
The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL
Natureworld

The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE9QSWlLOG8zNGFHcmFLTnpILTlhSks2SHA0LXktMjc4cW9TU1ZEYWdMb1FmZ1pYR2t1eFpPOS1UOWptRm9XdHBhUUVyV19Sc1g4Rmc3MFVfbEJTVWlfaXc?oc=5" target="_blank">The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
CAR-T Immunotherapy Keeps Cancer in Remission for 10 Years
Cancer Healthworld

CAR-T Immunotherapy Keeps Cancer in Remission for 10 Years

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNVzFRZklJd1NpUGRHbUtOdFVwTFJwUkRRTWlpN0hkZWM3eVV2c1R5TWNvdllSbVkxdVBVZ0VhRlNzbkZLZUppbFpBTkVoaDNOQlc5Vy1mclIwV1dOOFplSmZzbTR4Q2d4VlEyUU1VQkhLS2dlYS1wYXYzNHU4aVl6S3lhQUU1c1NWblVSMnNmbUc?oc=5" target="_blank">CAR-T Immunotherapy Keeps Cancer in Remission for 10 Years</a>  <font color="#6f6f6f">Cancer Health</font>

Read Full StoryMore like this
Discovery to delivery: solving the scaling challenge in cell therapy
Naturegeneral

Discovery to delivery: solving the scaling challenge in cell therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9sR05RUmx3UHVIYXRTT0JIZmpLU3h6SFc5SGJuYXVQWjBvSVNGNHdRSXM4Z1BRb2p1S1NjYlhzNGdqc3NmUTdTbnhydWQtR240SDdhRmZvS1dwWnZJSmVn?oc=5" target="_blank">Discovery to delivery: solving the scaling challenge in cell therapy</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A new way to miniaturize cell production for cancer treatment
MIT Newsgeneral

A new way to miniaturize cell production for cancer treatment

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQR0I0enlQZWNfVHdFTXdUdlVHaWJoS211dFFWWWJvSUpHczB6QW5hYS1aVlZoUjRjeDJFdlltbTJKZFVja1lYamxXNThtWUpaak5Mb3dFTF9lS0xKUzE2Ym11OHR6dlEwaEFkRWdoSTJDaVJuTllTeXkwN0NNbmRnSmdGZkJYRmUydmprWWlSVTQ?oc=5" target="_blank">A new way to miniaturize cell production for cancer treatment</a>  <font color="#6f6f6f">MIT News</font>

Read Full StoryMore like this
ICYMI: First pediatric patient to receive CAR-T cell therapy celebrates 10 years of being cancer-free
PhRMAgeneral

ICYMI: First pediatric patient to receive CAR-T cell therapy celebrates 10 years of being cancer-free

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQWUcxLURFQzRwZWthT3UySkVZRDZuRlhxRTlpZ1ZNMDJjQW1zWWFmcmhUMHRudWktemFSVGZfa0ppZGt4ZnJPMXhCelBwTHZ2VldPLTVidGhtYVgwbHlLbDg1Y3dhU3ZDTkNrZ2pVb25aNWU0eWppdWk2MHJUcUNpUVpNUGdpdUp5X0lQWnBFb3VDc25neWZfNjBKcGhuVndIM1QweElvakM2UXQtXzhySkF1Zm1ISzJiTk5zNkFqeDA?oc=5" target="_blank">ICYMI: First pediatric patient to receive CAR-T cell therapy celebrates 10 years of being cancer-free</a>  <font color="#6f6f6f">PhRMA</font>

Read Full StoryMore like this
"CAR T Cells Produce 10-Ye" — Live Google News Trends & Headlines